P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators
Giulia Berzero(Sorbonne Université), Marc Sanson(Centre National de la Recherche Scientifique), Chiara Villa(Centre National de la Recherche Scientifique), Karima Mokhtari(Inserm), Anna Luisa Di Stefano(Hôpital Foch), Y. Marie, Khê Hoang‐Xuan(Sorbonne Université), Jean-François Delattre(Sorbonne Université), Susanna Ronchi(University of Insubria)
Cited by 0
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial
|The Lancet|2005|1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
|European Journal of Cancer|2005|576